Trials
Search / Trial NCT05651295

A Precision Medicine Approach to Target Engagement for Emotion Regulation

Launched by MATTHEW SOUTHWARD · Dec 12, 2022

Trial Information

Current as of January 21, 2025

Recruiting

Keywords

Cognitive Behavior Therapy Mechanism Ecological Momentary Assessment Personalization

ClinConnect Summary

This clinical trial is exploring new ways to help people better manage their emotions, especially those who struggle with conditions like depression, anxiety, and PTSD. Researchers want to see if teaching individuals personalized skills—tailored to their specific needs—can help reduce the intensity of their negative emotions more effectively than standard methods. They will first test this with a group of participants and then use the findings to match new participants with the most suitable training for their emotional challenges.

To be eligible for this study, participants should be between the ages of 65 and 74 and experience difficulties with emotional regulation. This means they often have strong negative feelings that are hard to control. However, those who do not speak English well, do not have access to a smartphone, or need more intensive care than outpatient treatment are not eligible. If you join the trial, you can expect to learn different skills to help manage your emotions, and your progress will help researchers understand how to create better, personalized support for people facing similar challenges in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Elevated emotion dysregulation
  • Exclusion Criteria:
  • Lack of proficiency in English
  • No access to smartphone
  • Conditions requiring greater than outpatient care

Trial Officials

Matthew W Southward, Ph.D.

Principal Investigator

University of Kentucky

About Matthew Southward

Matthew Southward is a dedicated clinical trial sponsor specializing in the advancement of innovative therapeutic solutions. With a strong focus on enhancing patient outcomes, Southward oversees a range of clinical studies aimed at evaluating the safety and efficacy of novel treatments across various medical disciplines. Committed to adhering to rigorous regulatory standards and fostering collaborative partnerships, Matthew Southward ensures the highest levels of integrity and transparency throughout the research process, contributing to the overall progress of medical science and patient care.

Locations

Lexington, Kentucky, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials